Disease Prevention and Control Guidelines

• Biosafety
• Chronic Diseases
  • Arthritis
  • Cancer
  • Chronic Respiratory Diseases
  • Diabetes
  • Hypertension
  • Mental Illness
• Group A Streptococcal Disease
• Hepatitis C
• HIV/AIDS
• Infection Control
• Laboratory
• Sexually Transmitted Infections (STI)
• Travel Health/Quarantine
• Tuberculosis (TB)
• Vaccines and Vaccine-Preventable Diseases
• Publication Notes

Information on SARS for Health Professionals
www.sars.gc.ca

Biosafety

• Laboratory Biosafety Guidelines - 3rd Edition (2004)
• Laboratory Biosafety Guidelines (1996)
  • Material Safety Data Sheets (MSDS) (1997)
• Guidelines for Biomedical Facilities using Sheep as Research Animals (2000)

Chronic Diseases

• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Clinical Case Definition and Guidelines for Medical Practitioners

Arthritis

• American College of Rheumatology - Practice guidelines for rheumatic disease
• Getting a Grip Project - Arthritis Best Practices Guidelines
• AHRQ National Guideline Clearinghouse
• Rheumatoid Arthritis: Diagnosis and Management, CMA
• Diagnostic Guidelines, The John Hopkins Arthritis Center

Cancer

• Canadian Medical Association, CMA Infobase: Clinical Practice Guidelines
• B.C. Cancer Agency, various guidelines

Breast Cancer

• Canadian Medical Association, Clinical Practice Guidelines For the Care and Treatment of Breast Cancer, 2005
• Society of Obstetricians and Gynaecologists of Canada, Use of Hormonal Replacement Therapy After Treatment of Breast Cancer, 2004
• Alberta Ministry of Health and Wellness
• Canadian Medical Association, CMA Infobase: Clinical Practice Guidelines
• B.C. Cancer Agency, various guidelines

Cervical Cancer

• Cancer Care Ontario, Program in Evidence-Based Care: Practice Guidelines
• Cancer Care Ontario, Chemotherapy for Recurrent, Metastatic, or Persistent Cervical Cancer: A Clinical Practice Guideline, 2006
• Cancer Care Ontario, Primary Treatment for Locally Advanced Cervical Cancer: Concurrent Platinum-based Chemotherapy and Radiation Practice Guideline Report #4-5
• American Journal of Obstetrics & Gynecology, 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests, 2007
• Alberta Ministry of Health and Wellness
• Canadian Medical Association, CMA Infobase: Clinical Practice Guidelines
• B.C. Cancer Agency, various guidelines

Colorectal Cancer

• Cancer Care Ontario, Program in Evidence-Based Care: Practice Guidelines
• B.C. Ministry of Health: Follow-up of Patients after Curative Resection of Colorectal Cancer, 2004
• B.C. Ministry of Health: Detection of Colorectal Neoplasms in Asymptomatic Patients, (full guideline)
• B.C. Ministry of Health: Detection of Colorectal Cancer: A Guide for Patients
• Alberta Ministry of Health and Wellness
• Canadian Medical Association, CMA Infobase: Clinical Practice Guidelines
• B.C. Cancer Agency, various guidelines

Lung Cancer

• Cancer Care Ontario, Program in Evidence-Based Care: Practice Guidelines
• British Columbia Cancer Agency, Lung Cancer Management Guidelines
• Public Health Agency of Canada, Lung Cancer: Guidelines for Processing Specimens and Reporting Tumour Stage
• Canadian Medical Association, CMA Infobase: Clinical Practice Guidelines
• B.C. Cancer Agency, various guidelines

Melanoma Skin Cancer

• Cancer Care Ontario, Temozolomide for the Treatment of Metastatic Melanoma: A Clinical Practice Guideline
• Cancer Care Ontario, Biochemotherapy for the Treatment of Metastatic Malignant Melanoma: A Clinical Practice Guideline
• Alberta Cancer Board, Adjuvant Interferon in Cutaneous Melanoma
• Cancer Care Ontario, Systemic Adjuvant Therapy for Patients at High Risk for Recurrent Melanoma: A Clinical Practice Guideline
• Cancer Care Ontario, Single-Agent Interleukin-2 in the Treatment of Metastatic Melanoma: A Clinical Practice Guideline
• Cancer Care Ontario, Screening for Skin Cancer: A Clinical Practice Guideline
• Canadian Medical Association, CMA Infobase: Clinical Practice Guidelines
• B.C. Cancer Agency, various guidelines

Non Melanoma Skin Cancer

• Non-melanoma skin cancer: Guidelines for treatment and management in Australia
• Management of nonmelanoma skin cancer in 2007
• A Summary of Non-Melanoma Skin Cancer Guidelines
• Basal Cell Carcinoma, Squamous Cell Carcinoma and Related Keratinocyte Dysplasias - A Guide to Clinical Management in Australia (DRAFT)
• Guidelines Support Photodynamic Therapy for Several Nonmelanoma Skin Cancers
• Canadian Medical Association, CMA Infobase: Clinical Practice Guidelines
• B.C. Cancer Agency, various guidelines

Prostate Cancer

• Cancer Care Ontario, Program in Evidence-Based Care: Practice Guidelines
• American Urological Association, Guideline For the Management of Clinically Localized Prostate Cancer: 2007 Update
• Alberta Ministry of Health and Wellness, Guideline for the Use of PSA and the Early Diagnosis of Prostate Cancer, updated 2006
• Ontario Ministry of Health, Ontario Prostate Specific Antigen (PSA) Clinical Guidelines, summary 2002 update
• Canadian Medical Association, CMA Infobase: Clinical Practice Guidelines
• B.C. Cancer Agency, various guidelines

Chronic Respiratory Diseases

• Diagnosis and treatment of sleep disordered breathing in adults

Asthma

• Canadian Asthma Consensus Guidelines

Chronic Obstructive Pulmonary Disease (COPD)

• COPD Guidelines

Diabetes

• Canadian Diabetes Association - Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada
• Colleges of Physicians and Surgeons from individual provinces or territories may have developed their own clinical practice guidelines for particular circumstances.

Hypertension

• 2009 CHEP Recommendations for the Management of Hypertension

Mental Illness

• The Canadian Psychiatric Association Clinical Practice Guidelines

Group A Streptococcal Disease

• Guidelines for the Prevention and Control of Invasive Group A Streptococcal Disease (October 2006)

Hepatitis C

• Management and Treatment of Hepatitis C Virus in Patients with HIV and Hepatitis C Virus Coinfection: A Practical Guide for Health Care Professionals. The Canadian Journal of Infectious Diseases & Medical Microbiology. Sept/Oct 2007;18(5):293-303.
• Infection Control Guidelines - Prevention and Control of Occupational Infections in Health Care CCDR Volume 28S1, March 2002
• Nutrition Tips for People with Hepatitis C:
  Helping You Feel Your Best!
  Dealing With Discomforts
  (September 2003)

• Hepatitis C: A Nursing Guide (September 2002)

• Management Guidelines for the HCV-HIV Co-infected Adult (October 2000)
  -Executive Summary

• Reproductive Care of Women Living with Hep C Infection (October 2000)

HIV/AIDS

• Guides for People Living with HIV/AIDS

• Interim Advisory on Measles Revaccination of Persons with Acquired Immunodeficiency Syndrome (AIDS) (1996) (*)

• Guidelines for the Identification, Investigation and Treatment of Individuals with Concomitant Tuberculosis and HIV Infection (1992)

Infection Control

• Seasonal Influenza - Guidance: Infection Prevention and Control Measures for Healthcare Workers in Acute Care and Long-term Care Settings (2010)
• Essential Resources for Effective Infection Prevention and Control Programs: A Matter of Patient Safety--A Discussion Paper (2010)
• Classic Creutzfeldt-Jakob Disease in Canada
  Quick Reference Guide 2007
• Anaphylaxis: Statement on Initial Management in Non-hospital Settings (1995)
• Laboratory Biosafety Guidelines (1996)
• Classic Creutzfeldt-Jakob Disease in Canada (2002) (*)
• Advisory Notice: Infection Control for Creutzfeldt-Jakob Disease (1996) (*)
• Foot Care by Health Care Providers (1997) (*)
• Infection Control Guidelines - Hand Washing, Cleaning, Disinfection and Sterilization in Health Care (362 KB) in PDF Format Only
• Preventing Infections Associated with Indwelling Intravascular Access Devices (1997) (*)
• Routine Practices and Additional Precautions for Preventing the Transmission of Infection in Health Care - Revision of Isolation and Precaution Techniques (1999) (*)
• Guidelines for Control of Meningococcal Disease (1994)
• Construction-related Nosocomial Infections in Patients in Health Care Facilities: Decreasing the Risk of Aspergillus, Legionella and Other Infections
• Prevention and Control of Occupational Infections in Health Care (2002)
• Infection Control Guidance in a Non-Outbreak Setting, (In the Absence of SARS) When an Individual Presents to a Health Care Institution With a Respiratory Infection (2003-12-17) (144 KB) in PDF Format Only (*)
• Infection Control Guidance if there is a SARS Outbreak Anywhere in the World, When an Individual Presents to a Health Care Institution With a Respiratory Infection (2003-12-17) (146 KB) in PDF Format Only (*)
• Guidelines for Preventing the Transmission of Tuberculosis in Canadian Health Care Facilities and Other Institutional Settings (1996) (*)
• Canadian Contingency Plan for Viral Hemorrhagic Fevers and Other Related Diseases (1997) (*)

Laboratory

• Canadian External Quality Assessment - Advisory Group on Antibiotic Resistance (CEQA-AGAR) (1999)
• Laboratory Biosafety Guidelines - 3rd Edition (2004)
• Laboratory Biosafety Guidelines (1996)
• Material Safety Data Sheets (MSDS) (1997)
• Measles Surveillance: Guidelines for Laboratory Support (1999) (*)
• Guidelines for Biomedical Facilities using Sheep as Research Animals (2000)

Sexually Transmitted Infections (STI)

• Canadian Guidelines for Sexual Health Education
• Canadian Guidelines on Sexually Transmitted Infections
• Lymphogranuloma venereum (LGV) in Canada: Recommendations for Diagnosis and Treatment and Protocol for National Enhanced Surveillance (May 2005)
• UPDATE: Information on the Availability in Canada of Cefixime (Suprax) for the treatment of Gonorrhea (November 2003)
• Information on the Availability in Canada of Cefixime (Suprax) for the treatment of Gonorrhea (December 2002)
• Interim Recommendations: Alternatives to Spectinomycin for Gonorrhea Treatment (September 2001) (92 KB) in PDF Format Only
• A Report from Consultations on a Framework for Sexual and Reproductive Health (1999)

Travel Health/Quarantine

• Statement on Personal Protective Measures to Prevent Arthropod Bites (2005)
• Statement on Oral Cholera Vaccination (1998) (*)
• Dengue Fever and International Travel (1996) (*)
• Persistent Diarrhea In The Returned Traveller (1998)
• Statement on Japanese Encephalitis Vaccine (1998)
• Statement on Ethics and Travel (2003)
• Evidence-Based Medicine (1994) (112 KB) in PDF Format Only
• Fever in The International Traveller - Initial Assessment Guidelines (1997) (*)
• Statement on High Altitude Illnesses (1998) (*)
• Statement on Travellers and HIV/AIDS (1994)
• Immunization Recommendations for Travellers
• Statement On Travel, Influenza, And Prevention - Update (2005) (*)
• Statement on Travel, Influenza, and Prevention (2005) (*)
• Travel, Influenza and Prevention (1996) (*)
• Travel Statement on Jet Lag (2003)
• Canadian Recommendations for the Prevention and Treatment of Malaria Among International Travellers (2004) (*)
• Statement on Meningococcal Vaccination for Travellers (1999)
• Statement on Motion Sickness (2003)
• Statement on Motion Sickness (1996) (*)
• Poliomyelitis Vaccination for International Travellers (2003)
• Statement on Poliomyelitis Vaccination for International Travellers (1995)
• Statement on Travellers and Rabies Vaccine (2002)
• Guidelines for the Practice of Travel Medicine (1999)
• The Risk and Prevention of Tuberculosis in Travellers (1997) (*)
• Tuberculosis Screening and the International Traveller (1996) (*)
• Guidelines for the Investigation of Individuals Who Were Placed Under Surveillance for Tuberculosis Post-Landing in Canada (1992)
• Statement on Overseas Travellers and Typhoid (1994)
• Canadian Contingency Plan for Viral Hemorrhagic Fevers and Other Related Diseases (1997) (*)

Tuberculosis (TB)

• Canadian Tuberculosis Standards, 6th Edition (2007)
• Guidelines regarding departure from Canada of persons with suspected respiratory tuberculosis (TB), untreated active respiratory TB or partially treated active respiratory TB - (Version 2006.07.18)
• Statement on Bacille Calmette Gu?rin (BCG) Vaccine (2004)
• Guidelines for the investigation and follow-up of individuals under medical surveillance for tuberculosis after arriving in Canada: a summary (2003)
• Recommendations for the Screening and Prevention of Tuberculosis in Patients with HIV and the Screening for HIV in Tuberculosis Patients and Their Contacts (2002)
• Canadian guidelines for the investigation and follow-up of individuals under medical surveillance for tuberculosis after arrival in Canada (2001)
• Mycobacterium tuberculosis - Material Safety Data Sheet - Infectious Substances (2001)
• Management strategies for candidates for protease inhibitors and requiring treatment for Mycobacterium tuberculosis (1998)
• Guidelines for Preventing the Transmission of Tuberculosis in Canadian Health Care Facilities and other Institutional Settings (1996)

Vaccines and Vaccine-Preventable Diseases

Adverse Events (associated with vaccines)

• Guidelines for Reporting Adverse Events Associated with Vaccine Products (2000)

Cholera

• Statement on New Oral Cholera and Travellers' Diarrhea Vaccination (2005)
• Statement on Oral Cholera Vaccination (1998) (*)

Cochlear Implant Recipients

• Immunization Recommendations for Cochlear Implant Recipients (2003)

Diptheria

• Statement on the recommended use of pentavalent and hexavalent vaccines (1 February 2007)
• Interchangeability of Diphtheria, Tetanus, Acellular Pertussis, Polio, haemophilus Influenzae Type B Combination Vaccines Presently Approved for Use in Canada for Children < 7 Years of Age (2005)
• Statement On Adult/Adolescent Formulation of Combined Acellular Pertussis, Tetanus, and Diphtheria Vaccine (May 2000) (*)
• Guidelines for the Control of Diphtheria in Canada (July 1998) (*)

Encephalitis

• Statement on Japanese Encephalitis Vaccine (1998)

Haemophilus Influenzae Type B

• Statement on the recommended use of pentavalent and hexavalent vaccines (1 February 2007)
• Interchangeability of Diphtheria, Tetanus, Acellular Pertussis, Polio, haemophilus Influenzae Type B Combination Vaccines Presently Approved for Use in Canada for Children < 7 Years of Age (2005)
• Supplementary Statement on Newly Licensed Haemophilus Influenzae Type B (Hib) Conjugate Vaccines in Combination with other Vaccines Recommended for Infants (1994)

Hepatitis

• Statement on the recommended use of pentavalent and hexavalent vaccines (1 February 2007)
• Hepatitis B Vaccine, Update to the 2002 Canadian Immunization Guide 15 May 2004
• Update on Hepatitis A Vaccine (AVAXIM?, Aventis Pasteur), 2001 (*)
• Statement on Alternate Adolescent Schedule for Hepatitis B Vaccine, 2000 (*)
• Supplementary Statement on Hepatitis A Vaccine, 2000 (*)
• Statement on Combination Vaccines Against Hepatitis A And Hepatitis B (1999) (*)
• Supplementary Statement on Hepatitis Prevention - Hepatitis A and Hepatitis B Combination Vaccine for Children (1999) (*)
• Supplementary Statement on Hepatitis Prevention (1997) (*)
• Supplementary Statement on Hepatitis A Prevention (1996) (*)
• Report of the Hepatitis B Working Group (1994)

Immunization

• Canadian Immunization Guide, Seventh Edition, 2006
• Guidelines For Childhood Immunization Practices
• Canadian National Report on Immunization, 2006
• Canadian National Report on Immunization, 1998
• Canadian National Report on Immunization, 1997
• Canadian National Report on Immunization, 1996

Influenza

• Statement on Influenza Vaccination for the 2007-2008 Season - 1 July 2007
• Travel, Influenza, and Prevention (2005)
• Statement on Influenza Vaccination for the 2005-2006 Season (2005)
• Statement on Influenza Vaccination for the 2004-2005 Season (2004)
• Update: Statement on Influenza Vaccination for the 2003-2004 Season (2004)
• Statement on Influenza Vaccination for the 2003-2004 Season (2003)
• Statement on Influenza Vaccination for the 2002-2003 Season (2002)
• Supplementary Statement for the 2002-2003 Influenza Season: Update on Oculo-respiratory syndrome in Association with Influenza Vaccination (2002)
• Statement on Influenza Vaccination for the 2001-2002 Season (2001)

Measles

• Measles Surveillance: Guidelines for Laboratory Support (1998) (*)
• Interim Advisory on Measles Revaccination of Persons with Acquired Immunodeficiency Syndrome (AIDS) (1996) (*)
• Supplementary Statement on Measles Elimination in Canada (1996) (*)
• Guidelines for Control of Measles Outbreaks in Canada (1995)

MMR (Measles, Mumps, Rubella)

• Supplementary Statement on MMR Vaccine and Anaphylactic Hypersensitivity to Egg or Egg-Related Antigens (1996) (*)

Meningococcal

• Guidelines for the Prevention and Control of Meningococcal Disease - Supplement (2005)
• Update on Meningococcal C Conjugate Vaccines (2005)
• Supplementary Statement on Conjugate Meningococcal Vaccines (2003)
• Statement on Recommended Use of Meningococcal Vaccines (2001) (*)
• Statement on Meningococcal Vaccination for Travellers (1999)

Palivizumab

• Statement on the Recommended use of Monoclonal Anti-RSV Antibody (Palivizumab) (2003)

Pertussis

• Statement on the recommended use of pentavalent and hexavalent vaccines (1 February 2007)
• Proceedings of the National Microbiology Laboratory Pertussis Workshop, March 7, 2006
• Interchangeability of Diphtheria, Tetanus, Acellular Pertussis, Polio, haemophilus Influenzae Type B Combination Vaccines Presently Approved for Use in Canada for Children < 7 Years of Age (2005)
• Clarification - Prevention of Pertussis in Adolescents and Adults (2004)
• National Consensus Conference on Pertussis (2003)
• Prevention of Pertussis in Adolescents and Adults (2003)
• Statement On Adult/Adolescent Formulation of Combined Acellular Pertussis, Tetanus, and Diphtheria Vaccine (2000) (*)
• Statement on Pertussis Vaccine (1997) (*)
• Statement on Management of Persons Exposed to Pertussis and Pertussis Outbreak Control (1994)

Pneumococcal

• Recommendations for use of Pneumococcal 23-Valent Polysaccharide Vaccine During Shortage (2004)
• Statement on the Recommended use of Pneumococcal Conjugate Vaccine: Addendum (2003)
• Immunization Recommendations for Cochlear Implant Recipients (2003)
• Statement on Recommended use of Pneumococcal Conjugate Vaccine (2002)

Poliomyelitis

• Statement on the recommended use of pentavalent and hexavalent vaccines (1 February 2007)
• Interchangeability of Diphtheria, Tetanus, Acellular Pertussis, Polio, haemophilus Influenzae Type B Combination Vaccines Presently Approved for Use in Canada for Children < 7 Years of Age (2005)
• Poliomyelitis Vaccination for International Travellers (2003)

Rabies

• Update on Rabies Vaccines (2005)
• Statement on Travellers and Rabies Vaccine (2002)

Smallpox

• Statement on Smallpox Vaccination (2002)

Tetanus

• Statement on the recommended use of pentavalent and hexavalent vaccines (1 February 2007)
• Interchangeability of Diphtheria, Tetanus, Acellular Pertussis, Polio, haemophilus Influenzae Type B Combination Vaccines Presently Approved for Use in Canada for Children < 7 Years of Age (2005)
• Statement On Adult/Adolescent Formulation of Combined Acellular Pertussis, Tetanus, and Diphtheria Vaccine (May 2000) (*)

Thimerosal

• Updated Recommendations on the use of Thimerosal-Containing Vaccines in Canada (2005-12-01)
• Statement on Thimerosal (2003)
• Thimerosal in Vaccines (1999)

Vaccine

• Guidelines for Reporting Adverse Events Associated with Vaccine Products (2000)
• National Vaccine Storage and Handling Guidelines for Immunization Providers (2007)

Varicella

• Update on Varicella (2004)
• NACI Update to Statement on Varicella Vaccine (2002)
• Statement on Recommended Use of Varicella Virus Vaccine (1999) (*)

Notes

• The following guidelines have been published by PHAC to support Canada's disease prevention and control efforts. Many of them contain recommendations on specific public health topics issued either by the National Advisory Committee on Immunization (NACI), the Committee to Advise on Tropical Medicine and Travel (CATMAT) or the Advisory Committee on Epidemiology (ACE) as well as by numerous expert and scientific groups who collaborate with PHAC.
• Within each category, the guidelines are classified alphabetically by main topic or disease condition (appearing in bold) and then by year.